Meaningfully, SRI 31215 overcomes autocrine HGF/MET signaling-mediated the primary resistance to EGFR inhibitors (cetuximab and panitumumab) in colon cancer cells [76]. This evidence concerns the gene EGFR and colonic neoplasm.